[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: COVID-19 Patients with respiratory, heart, or kidney failure over 50 years of age in addition to conventional therapies received Depo\u2013 testosterone vial 200 ng/ml per week in male subjects and Medroxy Progesterone (Depo-Provera) 150mg/ml or progesterone intramuscular injection 60\u2009mg/d per day in female subjects. In case of positive effect on controlling the patient's symptoms and low level in the prepared sample, it can be repeated every week.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: COVID-19 patients with respiratory, heart or kidney failure above 50 years old which received common treatment for COVID-19 based on national protocol including Hydroxychloroquine 200 mg UID twice a day, Naproxen 200 mg UID twice a day, Azithromycin 250 per day.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1190, "treatment_name": "Sex hormon", "treatment_type": "Hormones", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]